Home
SCPH
SCPH News

Latest scPharmaceuticals Inc. (SCPH) News on June 4, 2025

scPharmaceuticals First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

19 days ago

scPharmaceuticals First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Thomson Reuters StreetEvents

20 days ago

Q1 2025 scPharmaceuticals Inc Earnings Call

scPharmaceuticals Inc (SCPH) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion

GuruFocus.com

20 days ago

scPharmaceuticals Inc (SCPH) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion

ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates

Zacks

20 days ago

ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

20 days ago

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

scPharmaceuticals Inc (SCPH) Q1 2025: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

22 days ago

scPharmaceuticals Inc (SCPH) Q1 2025: Everything You Need To Know Ahead Of Earnings

scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025

GlobeNewswire

a month ago

scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025

scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences

GlobeNewswire

a month ago

scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences

scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Report Preview: What To Expect

GuruFocus.com

2 months ago

scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Report Preview: What To Expect

scPharmaceuticals Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.

2 months ago

scPharmaceuticals Full Year 2024 Earnings: In Line With Expectations

Thomson Reuters StreetEvents

2 months ago

Q4 2024 scPharmaceuticals Inc Earnings Call

MT Newswires

2 months ago

Maxim Adjusts Price Target on scPharmaceuticals to $12 From $20, Keeps Buy Rating

scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic ...

GuruFocus.com

2 months ago

scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic ...

ScPharmaceuticals, Inc. (SCPH) Reports Q4 Loss, Tops Revenue Estimates

Zacks

2 months ago

ScPharmaceuticals, Inc. (SCPH) Reports Q4 Loss, Tops Revenue Estimates

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire

2 months ago

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025

GlobeNewswire

3 months ago

scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025

FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD

Pharmaceutical Technology

3 months ago

FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD

MT Newswires

3 months ago

scPharmaceuticals Says US FDA Approves Application to Expand Use of Furoscix

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

GlobeNewswire

3 months ago

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

Will Regenxbio (RGNX) Report Negative Earnings Next Week? What You Should Know

Zacks

3 months ago

Will Regenxbio (RGNX) Report Negative Earnings Next Week? What You Should Know

ScPharmaceuticals, Inc. (SCPH) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

3 months ago

ScPharmaceuticals, Inc. (SCPH) Expected to Beat Earnings Estimates: Should You Buy?

ImmunityBio (IBRX) Reports Q4 Loss, Misses Revenue Estimates

Zacks

3 months ago

ImmunityBio (IBRX) Reports Q4 Loss, Misses Revenue Estimates

scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences

GlobeNewswire

3 months ago

scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences

Shareholders in scPharmaceuticals (NASDAQ:SCPH) have lost 68%, as stock drops 12% this past week

Simply Wall St.

3 months ago

Shareholders in scPharmaceuticals (NASDAQ:SCPH) have lost 68%, as stock drops 12% this past week

scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

GlobeNewswire

4 months ago

scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

5 months ago

scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shift From Loss To Profit

Simply Wall St.

5 months ago

scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shift From Loss To Profit

Earnings Update: scPharmaceuticals Inc. (NASDAQ:SCPH) Just Reported And Analysts Are Trimming Their Forecasts

Simply Wall St.

7 months ago

Earnings Update: scPharmaceuticals Inc. (NASDAQ:SCPH) Just Reported And Analysts Are Trimming Their Forecasts

scPharmaceuticals Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

7 months ago

scPharmaceuticals Third Quarter 2024 Earnings: Misses Expectations

scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

GuruFocus.com

7 months ago

scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates

Zacks

7 months ago

ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates

MT Newswires

7 months ago

ScPharmaceuticals Q3 Loss Widens, Revenue Rises

scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

7 months ago

scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update

TScan Therapeutics (TCRX) Soars 7.6%: Is Further Upside Left in the Stock?

Zacks

7 months ago

TScan Therapeutics (TCRX) Soars 7.6%: Is Further Upside Left in the Stock?

GlobeNewswire

7 months ago

scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024

GlobeNewswire

8 months ago

scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024

Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains?

Zacks

8 months ago

Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains?

Investors in scPharmaceuticals (NASDAQ:SCPH) have unfortunately lost 23% over the last year

Simply Wall St.

9 months ago

Investors in scPharmaceuticals (NASDAQ:SCPH) have unfortunately lost 23% over the last year

scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

9 months ago

scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

After losing 35% in the past year, scPharmaceuticals Inc. (NASDAQ:SCPH) institutional owners must be relieved by the recent gain

Simply Wall St.

9 months ago

After losing 35% in the past year, scPharmaceuticals Inc. (NASDAQ:SCPH) institutional owners must be relieved by the recent gain

Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect?

Zacks

10 months ago

Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect?

Thomson Reuters StreetEvents

10 months ago

Q2 2024 scPharmaceuticals Inc Earnings Call

ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates

Zacks

10 months ago

ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates

scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

10 months ago

scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

scPharmaceuticals Announces Pricing of $50.0 Million Public Offering

GlobeNewswire

10 months ago

scPharmaceuticals Announces Pricing of $50.0 Million Public Offering

MT Newswires

10 months ago

ScPharmaceuticals Says Study on Potential Furosemide Autoinjector Achieves Goals

MT Newswires

10 months ago

scPharmaceuticals Secures FDA Approval of New Drug Application to Expand Furoscix Indication

scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors

GlobeNewswire

10 months ago

scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication in Heart Failure

GlobeNewswire

10 months ago

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication in Heart Failure

scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) Autoinjector

GlobeNewswire

10 months ago

scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) Autoinjector

scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

10 months ago

scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024

GlobeNewswire

10 months ago

scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024

MT Newswires

10 months ago

ScPharmaceuticals New Drug Application Seeking to Expand Furoscix Indication Accepted for Filing by FDA

scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease

GlobeNewswire

10 months ago

scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease

When Will scPharmaceuticals Inc. (NASDAQ:SCPH) Breakeven?

Simply Wall St.

10 months ago

When Will scPharmaceuticals Inc. (NASDAQ:SCPH) Breakeven?

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts

TipRanks

a year ago

These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts

Increases to scPharmaceuticals Inc.'s (NASDAQ:SCPH) CEO Compensation Might Cool off for now

Simply Wall St.

a year ago

Increases to scPharmaceuticals Inc.'s (NASDAQ:SCPH) CEO Compensation Might Cool off for now

scPharmaceuticals to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

scPharmaceuticals to Present at the Jefferies Global Healthcare Conference

Thomson Reuters StreetEvents

a year ago

Q1 2024 scPharmaceuticals Inc Earnings Call

GuruFocus.com

a year ago

scPharmaceuticals Inc (SCPH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...

ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates

Zacks

a year ago

ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates

scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

GlobeNewswire

a year ago

scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024

GlobeNewswire

a year ago

scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

GlobeNewswire

a year ago

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

Those who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 62%

Simply Wall St.

a year ago

Those who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 62%

scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript

scPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growth

GuruFocus.com

a year ago

scPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growth

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

GlobeNewswire

a year ago

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

GlobeNewswire

a year ago

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

GlobeNewswire

a year ago

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

scPharmaceuticals Inc.'s (NASDAQ:SCPH) Path To Profitability

Simply Wall St.

a year ago

scPharmaceuticals Inc.'s (NASDAQ:SCPH) Path To Profitability

Baldinger: How 49ers HC Kyle Shanahan creates numbers advantage for McCaffrey in run game

NFL Highlights

a year ago

Baldinger: How 49ers HC Kyle Shanahan creates numbers advantage for McCaffrey in run game

HOFT vs. WSC: Which Stock Should Value Investors Buy Now?

Zacks

a year ago

HOFT vs. WSC: Which Stock Should Value Investors Buy Now?

American Military University Wins Award from Council of College and Military Educators (CCME)

PR Newswire

a year ago

American Military University Wins Award from Council of College and Military Educators (CCME)

First Financial Corporation Reports 2023 Results

GlobeNewswire

a year ago

First Financial Corporation Reports 2023 Results

Lilium and AJW Group Form Strategic Collaboration on Material Management as part of Lilium’s Aftermarket Services

GlobeNewswire

a year ago

Lilium and AJW Group Form Strategic Collaboration on Material Management as part of Lilium’s Aftermarket Services

Down -20.21% in 4 Weeks, Here's Why OneWater Marine (ONEW) Looks Ripe for a Turnaround

Zacks

a year ago

Down -20.21% in 4 Weeks, Here's Why OneWater Marine (ONEW) Looks Ripe for a Turnaround

Canopy Growth to Report Third Quarter Fiscal 2024 Financial Results on February 9, 2024

CNW Group

a year ago

Canopy Growth to Report Third Quarter Fiscal 2024 Financial Results on February 9, 2024

Associated Press Finance

a year ago

Flushing Financial: Q4 Earnings Snapshot

Flushing Financial Corporation Reports 2023 and 4Q23 GAAP EPS of $0.96 and $0.27, and Core EPS of $0.83 and $0.25, Respectively; Continues to Successfully Execute On Its Action Plan

GlobeNewswire

a year ago

Flushing Financial Corporation Reports 2023 and 4Q23 GAAP EPS of $0.96 and $0.27, and Core EPS of $0.83 and $0.25, Respectively; Continues to Successfully Execute On Its Action Plan

Solid Power Announces $50 Million Share Repurchase Authorization

GlobeNewswire

a year ago

Solid Power Announces $50 Million Share Repurchase Authorization

MasterCraft Boat Holdings, Inc. to Webcast Fiscal Second Quarter 2024 Earnings Conference Call Wednesday, February 7, 2024

GlobeNewswire

a year ago

MasterCraft Boat Holdings, Inc. to Webcast Fiscal Second Quarter 2024 Earnings Conference Call Wednesday, February 7, 2024

Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice

Business Wire

a year ago

Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice

Software Development Stocks Q3 Earnings: Datadog (NASDAQ:DDOG) Best of the Bunch

StockStory

a year ago

Software Development Stocks Q3 Earnings: Datadog (NASDAQ:DDOG) Best of the Bunch

NVE Corporation (NASDAQ:NVEC) Q3 2024 Earnings Call Transcript

Insider Monkey

a year ago

NVE Corporation (NASDAQ:NVEC) Q3 2024 Earnings Call Transcript

With 41% stake, Hingham Institution for Savings (NASDAQ:HIFS) seems to have captured institutional investors' interest

Simply Wall St.

a year ago

With 41% stake, Hingham Institution for Savings (NASDAQ:HIFS) seems to have captured institutional investors' interest

AxoGen (NASDAQ:AXGN) shareholders have endured a 58% loss from investing in the stock three years ago

Simply Wall St.

a year ago

AxoGen (NASDAQ:AXGN) shareholders have endured a 58% loss from investing in the stock three years ago

Zacks Industry Outlook Highlights nVent Electric, Fabrinet and Stoneridge

Zacks

a year ago

Zacks Industry Outlook Highlights nVent Electric, Fabrinet and Stoneridge

Why Beyond Meat Stock Gained 22% in December

Motley Fool

a year ago

Why Beyond Meat Stock Gained 22% in December

Winners And Losers Of Q3: Bandwidth (NASDAQ:BAND) Vs The Rest Of The Software Development Stocks

StockStory

a year ago

Winners And Losers Of Q3: Bandwidth (NASDAQ:BAND) Vs The Rest Of The Software Development Stocks

scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue

GlobeNewswire

a year ago

scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue

Share on Social Networks: